Annie Curti, Director and Launch Excellence Lead at Novartis, brings over 15 years of experience in life sciences consulting and biopharma leadership. In this episode of Mastering Competitiveness, she shares what it takes to launch successfully in today’s complex pharma environment: from aligning cross-functional teams to defining the right success metrics and keeping patient needs at the center.
We discuss how launch teams can stay agile, balance global and local dynamics, and go beyond clinical differentiation to compete effectively from day one.
In this episode, we explore:
(03:37) How the healthcare stakeholder landscape is evolving
(08:08) Overcoming cross-functional collaboration challenges
(10:38) Reinventing the company with customer focus
(13:19) Enhancing patient-centric communication
(18:02) Exploring non-clinical competitive advantages
(20:20) Data-driven strategy and execution
(21:07) Competitiveness in pharma over the next 10 to 15 years
Koen Union, Global Head of Market Research & Insights at UCB Biopharma, joins Trilations' CEO Johan Vermeiren and COO Claire Versluys to discuss how pharma insights teams can drive business impact through benchmarking, AI, and global-to-local planning.
How can pharma companies stay competitive in a saturated market? In this episode, Tim Talomie, VP Oncology Global Marketing at Merck, shares insights on building a differentiated commercial strategy and aligning teams for impact.
What you'll learn:
Listen now and explore strategies for commercial success in pharma.
Follow Mastering Competitiveness for more insights from industry leaders.
How can medical affairs be a key driver of competitiveness rather than just a support function? In this first episode, Paul Burton, Chief Medical Officer at Amgen, discusses the evolving role of medical strategy in shaping corporate competitiveness.
What you'll learn:
Follow Mastering Competitiveness for more insights from industry leaders.